Effect of organically modified clay on mechanical properties, cytotoxicity and bactericidal properties of poly(ε-caprolactone) nanocomposites

The objective of this study was to evaluate the use of organically-modified clay nanoparticles in poly(epsilon-caprolactone) (PCL) for developing biodegradable composites. PCL nanocomposites reinforced with two different types of organically-modified clay (Cloisite 30B, C30B and Cloisite 93A, C93A) were prepared by melt-mixing. Morphology of PCL/clay nanocomposites characterized by scanning electron microscopy indicated good dispersion of nanoclay in the PCL matrix. Reinforcement of nanoclay in PCL enhanced mechanical properties without affecting thermal and degradation properties of PCL. Cytocompatibility of PCL/clay nanocomposites was studied using both osteoblasts and endothelial cells in vitro. Both composites (PCL/C30B and PCL/C93A) were cytotoxic with high toxicity observed for C30B even at low content of 1wt %. The cytotoxicity was found to arise due to leachables from PCL/clay composites. Electrical conductivity measurements of aqueous media confirmed leaching of cationic surfactant from the PCL/clay composites PCL matrix. Both composites were found to be bactericidal but C30B was more effective than C93A. Taken together, it was observed that organically-modified nanoclay as fillers in PCL improves mechanical properties and imparts bactericidal properties but with increased risk of toxicity. These PCL/clay composites may be useful as stronger packaging material with antibacterial properties but are not suited as biomedical implants or for food packaging applications.